Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
11.64%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
CSCIFCompany Name
COSCIENS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOSCIENS BIOPHARMA INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CSCIF - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.1M | 11.64% | $ 9.44M |
| 3/31/2025 | $ 1.21M | 13.38% | $ 9.03M |
| 12/31/2024 | $ 1.16M | 12.11% | $ 9.59M |
| 9/30/2024 | $ 298K | 6.88% | $ 4.33M |
| 6/30/2024 | $ 176K | 7.14% | $ 2.46M |
| 3/31/2024 | $ 22K | 0.93% | $ 2.37M |
| 12/31/2023 | $ 19K | 0.42% | $ 4.5M |
| 9/30/2023 | $ -32K | 0% | $ 6.86M |
| 6/30/2023 | $ -32K | 0% | $ 8.72M |
| 3/31/2023 | $ 7K | 0.11% | $ 6.25M |
Key Performance Insights, Last 5 Years
- COSCIENS BIOPHARMA INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, COSCIENS BIOPHARMA INC's average CapEx % has been 3.57%.
- The median CapEx % for COSCIENS BIOPHARMA INC during this period was 0.75%
- COSCIENS BIOPHARMA INC reached its highest CapEx % over the past 5 years at 13.38%.
- The lowest CapEx % recorded by COSCIENS BIOPHARMA INC in the same timeframe 0.11%
COSCIENS BIOPHARMA INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for COSCIENS BIOPHARMA INC is calculated as follows: CapEx [ $ -6K ] / Revenues [ $ 1.3M ]
(=) CapEx % [ 0% ] CSCIF - Capital Expenditures Margin, Last 5 years
0.11%
Minimum
Mar 31, 2023
13.38%
Maximum
Mar 31, 2025
3.57%
Average
0.75%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |